Neoadjuvant therapy for resectable pancreatic cancers

Hepatobiliary Surg Nutr. 2022 Aug;11(4):583-585. doi: 10.21037/hbsn-22-31.

Authors

Yosuke Inoue¹, Hiromichi Ito¹, Yu Takahashi¹

Affiliation

¹ Division of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

No abstract available

Publication types

Editorial
Comment